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Abstract: Two glucosinolates (glucoraphasatin and glucoraphanin) and their degradation products (raphasatin and sulforaphane) are 
secondary metabolites which have shown antioxidant properties and inhibitory properties against the hepatic cholesterol; these effects are 
very important for the prevention of cholesterol gallstones because in their pathophysiology there is an imbalance in the transport and 
secretion of cholesterol. These effects produce oxygen reactive species formation, which damages the hepatic and biliary tissues. 
Cholesterol gallstones are a public health problem; their pharmacological treatment is very limited and the invasive surgical treatment for 
symptomatic gallstones is the cholecystectomy. Current research focuses on the search for preventive treatments, as there are many risk 
factors associated with the development of gallstones; therefore, a natural therapeutic alternative may be the use of these glucosinolates and 
their degradation products. 
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Resumen: Dos glucosinolatos (glucorafasatina y glucorafanina) y sus productos de degradación (rafasatina y sulforafano) son metabolitos 
secundarios que han demostrado propiedades antioxidantes y propiedades inhibidoras contra el colesterol hepático; estos efectos son muy 
importantes para la prevención de cálculos biliares de colesterol porque en su fisiopatología existe un desajuste en el transporte y secreción 
del colesterol. Estos efectos producen la formación de especies reactivas de oxígeno, que dañan los tejidos hepático y biliar. Los cálculos 
biliares de colesterol son un problema de salud pública, su terapia farmacológica es muy limitada y el tratamiento quirúrgico invasivo para 
cálculos biliares sintomáticos es la colecistectomía. Las investigaciones actuales están orientadas a la búsqueda de tratamientos preventivos, 
porque hay muchos factores de riesgo asociados al desarrollo de cálculos biliares; por lo tanto, una alternativa terapéutica natural podría ser 
el uso de estos glucosinolatos, así como sus productos de degradación. 
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INTRODUCTION 
Cholesterol gallstones are prevalent in Western 
countries such as the United States and in Latin-
American countries such as Chile, Mexico and 
Argentina (Stinton and Shaffer, 2012). Due to the fact 
that this disease causes a considerable amount of 
medical appointments and hospitalizations, it is 
considered a public health problem for which there are 
is only a limited number of drugs that can be used for 
its treatment (Portincasa et al., 2012); the invasive 
prophylactic therapy for symptomatic gallstones is 
cholecystectomy, or the removal of the gallbladder 
(Maurer et al., 2009); therefore, investigations are 
focused on the search for preventive treatments, but 
the cost-benefit produced by the pharmacological and 
surgical treatment, coupled with the numerous risk 
factors for developing this disease (Portincasa and 
Wang, 2012). Various natural products that have 
preventive properties have been used in cholesterol 
gallstones research, some of them used in the 
traditional medicine. Glucosinolates are secondary 
metabolites present in the Brassicaceae family (Lelario 
et al., 2012). These natural products and their 
degradation products (isothiocyanates) have both been 
object of research due to their antioxidant properties, 
and it has recently been shown that these metabolites 
have the property of reducing hepatic cholesterol 
levels in in vivo models. (Hanlon et al., 2007; 
Rodríguez-Cantú et al., 2011). These effects might 
prevent the formation of cholesterol gallstones, as this 
gastrointestinal disorder is characterized by an 
imbalance in the concentration of hepatic cholesterol; 
the lipid is constantly secreted to the gallbladder, 
causing damage to the epithelium and the production 
of reactive oxygen species (Wang et al., 2009). 
Glucoraphasatin, raphasatin, glucoraphanin and 
sulforaphane are the glucosinolates which have shown 
to generate these important therapeutic effects. In their 
antioxidant activity have been reported trascendental 
action mechanisms in different enzymes, such as 
quinone reductase, glutathione s-transferases and 
thioredoxin reductase; the hypocholesterolaemic 
effects of glucosinolates are involved in the action 
mechanism of the sterol regulatory element-binding 
proteins (SREBP-1 and SRBP-2) and the fatty acid 
synthase enzyme (FAS) (Hanlon et al., 2007; 
Rodríguez-Cantú et al., 2011). In this review we 
discuss the reports that support these therapeutic 
effects and we present important information from 
databases such as PubMed, ScienceDirect and SciELO 
in order to discuss the effect of two glucosinolates 
regarding the prevention of gallstones. All prospective 
randomized controlled clinical studies and preclinical 
studies of cholesterol gallstones disease were 
considered. Articles written in English and Spanish 
were included in the search. The articles analyzed 
range from 2006 to 2012; we found them using 
keywords: glucosinolates, glucoraphasatin, 
glucoraphanin, Brassicaceae, reactive oxygen species, 
antioxidant, gallstones, cholesterol, gallbladder disease 
and biliary lipids. Most experimental studies analyzed 
were published in journals with a high impact factor.  
 
RESULTS 
We collected 80 papers, including review articles, 
clinical studies and basic experiments. Overall, 43 
articles were eligible for the review. We selected two 
articles from the SciElO database and all remaining 
articles (41) were selected from the PubMed and 
ScienceDirect databases. Each manuscript was 
evaluated on the basis of scientific rigor of our article, 
considering the adequacy of the data, importance and 
originality of the studies, adequacy of the literature 
citations, clarity of the presentation, interest to the 
Journal's readership and our conclusion. 
 
Cholesterol gallstones disease 
This disease is the most common disorder of the 
gastrointestinal system, with a prevalence of 10%-15% 
in the Western population; Chile and Mexico are the 
countries with the highest prevalence of cholesterol 
gallstones in Latin-America, the genetic aspects being 
very important in these regions (Stokes et al., 2011; 
Kovacs et al., 2008). There are numerous risk factors 
associated with the development of cholesterol 
gallstones: female sex, obesity, sedentary lifestyle, 
high-fat diet, advanced age, hypercholesterolemia, 
among others (Stokes et al., 2011). The 
pathophysiology of cholesterol gallstones is complex 
and polygenic, many proteins and nuclear receptors 
are implicated in the hypersecretion of biliary 
cholesterol, crystallization/nucleation of cholesterol, 
biliary sludge formation, gallbladder stasis and 
intestinal hypomotiliy (Stokes and Lammert, 2012; 
Castro-Torres, 2012). Cholesterol homeostasis is very 
important within gallstones pathophysiology, because 
is the consequence of the complex regulatory 
mechanisms involving intestinal absorption and 
hepatic synthesis, as well as biliary secretion 
(Portincasa and Wang, 2012). These imbalances are 
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combined with all the pathophysiological process that 
takes place within the gallbladder, such as 
hypersecretion of mucin gel, inflammation reactions, 
alterations in immunological system and stasis 
(Maurer et al., 2009). Thus many proteins are 
implicated in biliary lipids secretion and are regulated 
it by several transcription factors, including nuclear 
receptors LXR and FXR (Vázquez et al., 2012). Bile 
salts, phospholipids and cholesterol are the three major 
lipids present in the bile and its transporters such as 
ABCB4, ABCB11, ABCG5, ABCG8 and NPC1L1 
protein are involved in pathogenesis of gallstones 
(Stokes and Lammert, 2011).  
Two cholesterol transport processes are 
important for the prevention of cholesterol gallstones: 
biliary secretion and intestinal absorption (Portincasa 
and Wang, 2012), and most of the research for a 
treatment is based on them. Currently, there is a drug 
called ezetimibe that inhibits the expression of the 
Niemann-Pick type C1 type 1 (NPC1L1) protein, 
thereby diminishing intestinal cholesterol absorption 
(de Bari et al, 2012). Ezetimibe inhibits the formation 
of cholesterol gallstones in mice (Wang et al, 2008; 
Zúñiga et al., 2008), but there are no specific clinical 
studies that evaluate NPC1L1 expression in gallstones 
prevention. Other prophylactic drugs are 
ursodeoxycholic acid and statins (Wang et al., 2008; 
Ahmed et al., 2011); it is important to consider that 
when gallstones are already formed, these therapeutic 
agents present a low capacity to dissolve them, 
ursodeoxycholic acid being the most used drug, but in 
order for it to work the gallstones must be radiolucent 
and the motility of gallbladder should not be altered 
(Tuncer et al., 2012). Although scientific research on a 
future therapeutic target is centered on cholesterol 
transport sites, it is important to consider the formation 
of reactive oxygen species as a result of the high 
concentration of hepatic cholesterol; these imbalances 
might be inhibited by the effect of glucosinolates and 
their hydrolysis products, but it is necessary to 
continue research on natural products, as they are 
considered important alternative treatments. 
 
Glucosinolates 
Glucosinolates constitute a well-defined group of plant 
secondary metabolites, with a characteristic structure 
and biochemistry. Structurally, they are anions 
composed of thiohydroximates that carry a sulphur-
linked -glucopyranosyl residue, an oxygen-linked 
sulfate residue, and an amino acid-derived, variable 
side chain (Figure 1). Occasionally, further 
substituents are attached to oxygen, sulfur or nitrogen 
atoms of the side chain or to the glucosyl moiety 
(Agerbirk and Olsen, 2012). Glucosinolates are 
structurally diverse and in recent years there has been 
major advances in understanding the molecular 
genetics and the biochemistry of their biosynthesis and 
accumulation. Glucosinolates are synthesized from a 
small number of primary amino acids such as tyrosine, 
phenylalanine and tryptophan (Sønderby et al., 2010). 
These secondary metabolites are found inside 
vacuoles, myrosinase being the enzyme responsible 
for hydrolyzing them into different products of 
degradation, such as nitriles, isothiocyanates and 
thiocyanates (Peñas et al, 2011). Most plants 
containing glucosinolates belong to the Brassicaceae 
family, also known as cruciferous; it includes radish, 
spinach, broccoli, cabbage, cauliflower, turnip, 
mustard, Brussels sprouts, capers, daikon, watercress 
and wasabi (Mithen et al., 2010). The pungent taste of 
these vegetables, and of the condiments and flavoring 
agents that are prepared with them, comes from the 
products of the myrosinase reaction that occurs soon 
after the tissue of the plant is damaged (Dinkova-
Kostova and Kostov, 2012). The importance of this 
reaction for plant defense is emphasized by the 
extreme degree of metabolic specialization, including 
the degradation of cellular organelles, that takes place 
during the differentiation of the glucosinolate-rich 
sulphur cells (Tripathi and and Mishra, 2007; Mithöfer 
and Boland, 2012). The biology of glucosinolates is 
intrinsically connected to their characteristic chemistry 
and biochemistry; their degradation products are 
detrimental to a large number of organisms (Halkier 
and Gershenzon, 2006; Vig et al., 2009). In some 
cases, glucosinolates and/or their products are 
involved in herbivore insect defense against predators 
(Müller, 2009). Glucoraphasatin and glucoraphanin 
are the most studied glucosinolates and are found 
mainly in radishes and broccoli. These glucosinolates 
have shown significant antioxidant and 
hypocholesterolemic properties, which can be related 
to the prevention of cholesterol gallstones (Figure 2). 
No toxicity related to the different therapeutic effects 
of glucoraphasatin and glucoraphanin has been 
reported, but, with respect to cholesterol gallstones 
treatment, we have reported that the DL50 of black 
radish juice is over 5000 mg/kg and this plant has a 
high glucraphasatin concentration (Castro-Torres et 
al., 2012). These results allow us to think that juice 
black radish is not toxic, that it is effective and that it 
is not necessary to look for a lethal dose at higher 
values than the one we analyzed because therapeutic 
effects produced with minimal doses are preferred. 
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Figure 1 
Chemical structure of glucosinolates.  
The basic structure of glucosinolates comprises a glucose residue, a sulfate group, and a variable aglycone. 
Glucosinolate content varies with the species, the plant part and the cultivation and climatic conditions. 
 
Glucoraphasatin. Glucoraphasatin is a glucosinolate 
mainly found in radish roots and sprouts (Montaut et 
al., 2010). This secondary metabolite is present in 
black radish (Raphanus sativus L. var niger) (Hanlon 
et al., 2009). Black radish has important 
ethnobotanical uses for the treatment of pigment and 
cholesterol gallstones in the Mexican traditional 
medicine. In mice fed with a lithogenic diet, the juice 
of black radish significantly decreased cholesterol and 
triglycerides levels and increased HDL levels (Castro-
Torres and Naranjo-Rodríguez, 2012); the metabolism 
of cholesterol and triglycerides is very important in the 
pathophysiology of cholesterol gallstones (Smelt, 
2010). Treatment with black radish juice at three 
concentrations (concentrated, diluted one hundredfold 
1:100 and tenfold 1:10 in purified water) during 6 
days, dissolved cholesterol gallstones in mice (Castro-
Torres et al., 2012). The concentration of 
glucoraphasatin in an aqueous extract of the root of 
black radish is very high (approximately 30 mol of 
glucoraphasatin per gram of radish dry weight) 
compared with other glucosinolates (Hanlon et al., 
2007), and this glucosinolate is probably involved in 
the beneficial effect of decreasing cholesterol and 
triglycerides levels and dissolving cholesterol 
gallstones. Glucoraphasatin is metabolized into an 
isothiocyanate called raphasatin, which causes 
significant induction of detoxification enzymes (Scholl 
et al., 2011; Abdull-Razis et al., 2012). Raphasatin 
increases the activity of quinone reductase in HepG2 
cells at concentrations of 1-30 M (Hanlon et al., 
2007), and also activates the antioxidant response 
element in cell lines (Scholl et al., 2011). 
 
Glucoraphanin .Glucoraphanin is a secondary 
metabolite found naturally in black radish (in an 
aqueous extract of this plant, there is approximately 4 
mol of glucoraphanin per gram of radish dry weight). 
Broccoli sprouts are also very rich in glucoraphanin, 
which is enzymatically converted to sulforaphane 
(Hanlon et al., 2007; Rodríguez-Cantú et al., 2011). 
Sulforaphane is a potent chemopreventive agent, 
widely consumed in diets or as a diet supplement. This 
metabolite modulates phase II and III metabolic 
enzymes (Lubelska, et al., 2012). Glucoraphanin and 
sulforaphane affects cholesterol homeostasis by 
reducing hepatic cholesterol levels, an important effect 
for decreasing biliary cholesterol secretion and 
preventing the formation of cholesterol gallstones. 
 
Antioxidant effects can prevent the formation of 
gallstones 
Glucosinolates and isothiocyanates are known for their 
antioxidant properties, which are associated with 
cancer prevention (Fahey et al., 2012). However, the 
antioxidant effects of these compounds have not been 
studied in other pathologies. It is known that low 
levels of antioxidant nutrients and an imbalance in 
glutathione levels, the main antioxidant molecule in 
humans, are characteristic of gallstones disease 
(Khokonov, 2011; Vítek and Carey, 2012). A study 
was conducted in Hungary for evaluating the effect of 
the juice extracted from black radish root in male 
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Wistar rats fed with a hyperlipidaemic diet 
(cholesterol 2%, colic acid 0.5% and fat 20%). In this 
experiment, rats were given a 1:10 dilution of the 
extracted juice ad libitum for 9 days. The results 
showed a significant difference with respect to the 
products derived from lipid peroxidation between 
treated and untreated rats. In the same study, the 
untreated group showed a decrease in glutathione 
peroxidase enzyme levels compared to the treated 
group (Lugasi et al., 2005); it is known that diets rich 
in fats affect the efficacy of the blood antioxidant 
system. This study is important for the ongoing 
research about cholesterol gallstones prevention. The 
hyperlipidaemic diet administered to Wistar rats 
produced gallstones in mice because these organisms 
have a gallbladder, while rats cannot produce 
gallstones because they lack a gallbladder. The 
treatment with black radish juice produced significant 
antioxidant effects in rats, the same that can be 
expected in mice; these effects have the capacity to 
prevent the formation of gallstones. Black radish, in 
contrast to other cruciferous plants, is used in 
traditional medicine to prevent and dissolve 
cholesterol and pigmented gallstones, aspects that 
reinforce the scientifically demonstrated therapeutic 
effects associated to the prevention of gallstones. 
Antioxidant enzymes prevent the formation of 
reactive oxygen species, which are known to reduce 
gallbladder motility, another important factor that 
predisposes people to the development of gallstones 
disease. Hence, it is important to consider the study of 
metabolites that are able to induce the expression of 
antioxidant enzymes that prevent the formation of 
gallstones, such as raphasatin, a potent inducer of 
enzymatic detoxification. Raphasatin (10 M) induces 
the expression of relevant enzymes involved in 
enzymatic phase II detoxification such as quinone 
reductase, heme oxygenase and thioredoxin reductase 
in liver cell lines (HepG2) (Hanlon et al., 2007). 
Another study, which took place in the US, showed 
that the aerial parts (stem and leaves) of black radish 
were more effective for inducing the expression of 
antioxidant enzymes involved in enzymatic phase I 
and phase II detoxification (Hanlon et al., 2009). 
Altogether, these studies in cell lines have documented 
the significant antioxidant effect of black radish. In 
gallstones disease, reactive oxygen species act on both 
the liver and the gallbladder. In the gallbladder they 
induce cellular infiltration, edemas, granular 
hyperplasia and hypersecretion of mucin, resulting in 
the formation of biliary sludge and the accelerated 
formation of gallstones (Koppisetti, 2008); moreover, 
reactive oxygen species increase cholesterol 
crystallization. Therefore, antioxidant enzymes play a 
big role in preventing pathophysiological disorders 
associated to gallstones disease.  
 
Inhibition of hepatic cholesterol levels 
It has been observed that an increase in the secretion 
of cholesterol to the gallbladder is one of the necessary 
conditions for the formation of gallstones (Van 
Erpecum, 2011); it results from high cholesterol levels 
in hepatocytes; for this reason, the inhibition of high 
concentrations of hepatic cholesterol is a relevant 
target for the prevention of gallstones disease. In a 
study that used Syrian hamsters fed with a 
hypercholesterolaemic diet for 7 weeks, freeze-dried 
broccoli sprouts (Brassica oleracea var italica), high 
in glucoraphanin and sulforaphane, showed a 
significant decrease of hepatic cholesterol levels. 
These two metabolites decreased hepatic cholesterol 
levels, and this effect was associated to a decrease in 
the expression of SREBP-1, SREBP-2 and FAS 
(Rodríguez-Cantú et al., 2011); these proteins are 
known to play a relevant role in cholesterol and plant 
sterols homeostasis.  The Syrian hamster has been 
widely accepted as a good animal model in gallstones 
formation studies; therefore, the results have shown 
that under a lithogenic diet, glucoraphanin and 
sulforaphane may play an important role in preventing 
the formation of gallstones by decreasing cholesterol 
levels. However, in the reported study, a 
hypercholesterolaemic diet was used, which was 
unable to induce the formation of gallstones. These 
results are inconclusive, as it is known that other 
proteins, such as those involved in the transport of 
cholesterol from the liver to the bile ducts, play a 
relevant role in gallstones formation; for example, 
proteins present in the hepatocyte canalicular 
membrane (ABCG5 and ABCG8). However, there are 
few studies on the transport and regulation mechanism 
of cholesterol inside hepatocytes and more studies are 
needed to fully understand SREB proteins, which are 
transcription factors involved in the homeostasis and 
biosynthesis of cholesterol in hepatocytes (Khesht and 
Hassanabadi et al., 2012). In C57L7J mice susceptible 
to gallstones formation, the abnormal expression of the 
SREBP-2 protein is associated with an increase in the 
secretion of cholesterol into the bile. Glucosinolates 
are known to inhibit the expression of this protein and, 
thereby, to induce a decrease in cholesterol secretion. 
SRBP-2 is also known to modulate the protein NPC1 
L1, which is involved in the transport of cholesterol 
and inhibits its intestinal absorption (Pramfalk et al., 
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2010). Further studies are required to fully understand 
the effects of glucosinolates and of their degradation 
products on the transport proteins of cholesterol, 
which could represent an alternative preventive 
therapy with few adverse effects. 
 
 
 
 
Figure 2 
Antioxidant and hypocholesterolemic effects of glucoraphasatin, glucoraphanin and their degradation 
products. These effects can prevent the appearance of oxygen reactive species, which can appear in 
conditions of cholesterol gallstones, due to the high concentration of hepatic cholesterol. Glucoraphasatin 
exerts antioxidant activity by modulation in the expression of different hepatic antioxidant enzymes. 
Glucoraphanin inhibits hepatic cholesterol levels through the expression changes in enzymes and nuclear 
receptors of cholesterol metabolism. 
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CONCLUSION 
The antioxidant and hypocholesterolaemic effects 
exerted by glucoraphasatin, glucoraphanin and their 
degradation products are very important for the 
prevention of cholesterol gallstones, a highly prevalent 
gastrointestinal disease; therefore, it is crucial to 
investigate the possible action mechanism that allows 
these secondary metabolites to prevent the 
development of this disease. 
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